- Home
- TECX vs TCMD Comparison
TECX vs TCMD Comparison
Compare TECX & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- TCMD
- Stock Information
- Founded
- TECX 2019
- TCMD 1995
- Country
- TECX United States
- TCMD United States
- Employees
- TECX N/A
- TCMD N/A
- Industry
- TECX
- TCMD Medical/Dental Instruments
- Sector
- TECX
- TCMD Health Care
- Exchange
- TECX Nasdaq
- TCMD Nasdaq
- Market Cap
- TECX 334.4M
- TCMD 314.0M
- IPO Year
- TECX 2018
- TCMD 2016
- Fundamental
- Price
- TECX $19.81
- TCMD $9.97
- Analyst Decision
- TECX Buy
- TCMD Hold
- Analyst Count
- TECX 7
- TCMD 3
- Target Price
- TECX $78.67
- TCMD $16.00
- AVG Volume (30 Days)
- TECX 156.7K
- TCMD 289.6K
- Earning Date
- TECX 08-13-2025
- TCMD 08-04-2025
- Dividend Yield
- TECX N/A
- TCMD N/A
- EPS Growth
- TECX N/A
- TCMD N/A
- EPS
- TECX N/A
- TCMD 0.66
- Revenue
- TECX N/A
- TCMD $293,164,000.00
- Revenue This Year
- TECX N/A
- TCMD $7.96
- Revenue Next Year
- TECX N/A
- TCMD $8.53
- P/E Ratio
- TECX N/A
- TCMD $15.10
- Revenue Growth
- TECX N/A
- TCMD 5.96
- 52 Week Low
- TECX $13.70
- TCMD $8.61
- 52 Week High
- TECX $61.07
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- TECX 40.56
- TCMD 41.97
- Support Level
- TECX $22.13
- TCMD $9.80
- Resistance Level
- TECX $25.75
- TCMD $10.67
- Average True Range (ATR)
- TECX 1.44
- TCMD 0.34
- MACD
- TECX -0.48
- TCMD 0.09
- Stochastic Oscillator
- TECX 10.68
- TCMD 19.54
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.